Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1978 May; 71(5): 324–330.
PMCID: PMC1436599

The state of British medicine. 5. The innovation, benefits, drawbacks and control of drugs.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Dollery CT, Rawlins MD. Monitoring adverse reactions to drugs. Br Med J. 1977 Jan 8;1(6053):96–97. [PMC free article] [PubMed]
  • Lawson DH, Henry DA. Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"? Br Med J. 1977 Mar 12;1(6062):691–692. [PMC free article] [PubMed]
  • Wardell WM. Therapeutic implications of the drug lag. Clin Pharmacol Ther. 1974 Jan;15(1):73–96. [PubMed]
  • Wilson AB. Post-marketing surveillance of adverse reactions to new medicines. Br Med J. 1977 Oct 15;2(6093):1001–1003. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press